New drug aims to keep night shift workers awake and safe

NCT ID NCT06568367

First seen Jun 24, 2026 · Last updated Jul 24, 2026 · Updated 3 times

Summary

This Phase 3 trial tests whether the drug solriamfetol can reduce excessive sleepiness in people with shift work disorder. About 520 adults who work night shifts will take either solriamfetol or a placebo daily for 12 weeks. The study measures how well they stay awake and their overall sleepiness levels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Solriamfetol (a medication that promotes wakefulness)
What this could lead to
If successful, this could provide a new treatment option to help people with shift work disorder stay awake and alert during night shifts.
What could go wrong
This is a Phase 3 trial, but solriamfetol is already approved for other sleep conditions. However, it may not work for everyone, and side effects like headache or nausea are possible.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EXCESSIVE SLEEPINESS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Clinical Research Site

    RECRUITING

    Auburn, Alabama, 36832, United States

  • Clinical Research Site

    RECRUITING

    Cullman, Alabama, 35055, United States

  • Clinical Research Site

    RECRUITING

    Chandler, Arizona, 85224, United States

  • Clinical Research Site

    WITHDRAWN

    Tucson, Arizona, 85704, United States

  • Clinical Research Site

    RECRUITING

    Little Rock, Arkansas, 72211, United States

  • Clinical Research Site

    RECRUITING

    Anaheim, California, 92801, United States

  • Clinical Research Site

    RECRUITING

    Cerritos, California, 90703, United States

  • Clinical Research Site

    TERMINATED

    Chula Vista, California, 91910, United States

  • Clinical Research Site

    RECRUITING

    Huntington Beach, California, 92647, United States

  • Clinical Research Site

    RECRUITING

    Long Beach, California, 90805, United States

  • Clinical Research Site

    RECRUITING

    Santa Ana, California, 92705, United States

  • Clinical Research Site

    RECRUITING

    Colorado Springs, Colorado, 80918, United States

  • Clinical Research Site

    RECRUITING

    Brandon, Florida, 33511, United States

  • Clinical Research Site

    RECRUITING

    Hialeah, Florida, 33016, United States

  • Clinical Research Site

    RECRUITING

    Miami, Florida, 33135, United States

  • Clinical Research Site

    WITHDRAWN

    Miami, Florida, 33144, United States

  • Clinical Research Site

    RECRUITING

    Miami, Florida, 33176, United States

  • Clinical Research Site

    RECRUITING

    Miami Lakes, Florida, 33016, United States

  • Clinical Research Site

    RECRUITING

    Atlanta, Georgia, 30238, United States

  • Clinical Research Site

    RECRUITING

    Stockbridge, Georgia, 30281, United States

  • Clinical Research Site

    RECRUITING

    Chicago, Illinois, 60634, United States

  • Clinical Research Site

    RECRUITING

    Kenner, Louisiana, 70065, United States

  • Clinical Research Site

    RECRUITING

    Towson, Maryland, 21286, United States

  • Clinical Research Site

    RECRUITING

    Boston, Massachusetts, 02115, United States

  • Clinical Research Site

    RECRUITING

    Lansing, Michigan, 48911, United States

  • Clinical Research Site

    RECRUITING

    Novi, Michigan, 48377, United States

  • Clinical Research Site

    RECRUITING

    Southfield, Michigan, 48075, United States

  • Clinical Research Site

    RECRUITING

    Chesterfield, Missouri, 63017, United States

  • Clinical Research Site

    RECRUITING

    St Louis, Missouri, 63123, United States

  • Clinical Research Site

    RECRUITING

    Henderson, Nevada, 89052, United States

  • Clinical Research Site

    RECRUITING

    Middletown, New Jersey, 07748, United States

  • Clinical Research Site

    RECRUITING

    Denver, North Carolina, 28037, United States

  • Clinical Research Site

    RECRUITING

    Fayetteville, North Carolina, 28304, United States

  • Clinical Research Site

    RECRUITING

    Huntersville, North Carolina, 28078, United States

  • Clinical Research Site

    RECRUITING

    Cincinnati, Ohio, 45212, United States

  • Clinical Research Site

    RECRUITING

    Cincinnati, Ohio, 45245, United States

  • Clinical Research Site

    RECRUITING

    Wyomissing, Pennsylvania, 19610, United States

  • Clinical Research Site

    RECRUITING

    Charleston, South Carolina, 29425, United States

  • Clinical Research Site

    RECRUITING

    Columbia, South Carolina, 29201, United States

  • Clinical Research Site

    RECRUITING

    Houston, Texas, 77058, United States

  • Clinical Research Site

    RECRUITING

    Houston, Texas, 77070, United States

  • Clinical Research Site

    RECRUITING

    San Antonio, Texas, 78229, United States

  • Clinical Research Site

    RECRUITING

    Sugar Land, Texas, 77478, United States

  • Clinical Research Site

    RECRUITING

    Spokane, Washington, 99204, United States

  • Clinical Research Site

    RECRUITING

    Calgary, Alberta, T2Z 3A6, Canada

  • Clinical Research Site

    RECRUITING

    Markham, Ontario, L3R 1A3, Canada

  • Clinical Research Site

    RECRUITING

    Ottawa, Ontario, K2C 0P7, Canada

  • Clinical Research Site

    RECRUITING

    Toronto, Ontario, M4N 4M5, Canada

  • Clinical Research Site

    RECRUITING

    Toronto, Ontario, M5S 3A3, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.